My watch list  

626 Current news from israel

matching the following criteria

Evolva and Valent BioSciences to co-develop agricultural bioactives


Evolva and Valent BioSciences Corporation (VBC), a subsidiary of Sumitomo Chemical Company, have signed an exclusive agreement to co-develop and commercialise a class of high-value active ingredients for use as next-generation agricultural bioactives. For competitive reasons, the ingredients are ...


Spinal cord neurons that control pain and itch


The spinal cord transmits pain signals to the brain, where they are consciously perceived. But not all the impulses arrive at their destination: Certain neurons act as checkpoints and determine whether a pain signal is relayed or not. Researchers from UZH identified these neurons and their ...


Polyphor appoints Michael Altorfer as new CEO


Polyphor Ltd announced the appointment of Michael Altorfer as new CEO and successor of Jean-Pierre Obrecht as of March 31, 2015. Jean-Pierre Obrecht will continue to support the company in his role as a Member of the Board of Directors.Michael Altorfer joined Polyphor in 2001. He has served ...


Prexton Therapeutics raises €8.7 million ($10 million) in a Series A round


Prexton Therapeutics announced the closing of a Series A financing of €8.7 million ($10 million) co-led by Sunstone Capital and Ysios Capital. MS Ventures, the company's founding investor, will also participate. This first funding will help Prexton Therapeutics to develop novel small molecules ...


KUROS Announces grant of US Patent For its synthetic hydrogel technology


Kuros Biosurgery AG announced that its patent application U.S.S.N 12/102,157 was issued and has been assigned U.S. Patent No. 8,961,947. The addition of this granted patent further strengthens Kuros’ position in synthetic in-situ forming biomaterials. Kuros is developing a portfolio of ...


Mechanical thrombectomy improves outcomes in acute ischemic stroke


Stroke resulting from rupture or interruption of blood flow in brain vessels can lead to devastating consequences for patients, their families and society. Steady progress has been achieved in the last 20 years in stroke treatment through better prevention, establishment of stroke care units and ...


GlycoVaxyn AG sells its shares to GSK


GSK, who was already a minority shareholder in GlycoVaxyn, acquires the company and its biological conjugation platform which may help it to develop a new generation of prophylactic vaccines against bacterial infections. GSK has today paid $190 million to purchase the remaining stake in the ...


image description
Game Theory Explains Social Interactions of Cancer Cells


Researchers at the University of Basel and the University of East Anglia were able to predict the interactions of cancer cells using game theory. Their results have been published by the scientific journal PNAS. A tumor consists of a heterogeneous population of individual cells that compete for ...


Lonza Continues to Make Measurable Progress in Its Transformation


In 2014 Lonza delivered expected CORE EBIT growth of 11% in constant exchange rates (CER) (+9% in reported currency), compared with 2013. Lonza’s overall results confirm the updated guidance communicated during the third-quarter update. Both of Lonza’s segments – Specialty Ingredients and ...


Damaged DNA amplified


In the majority of cases, the onset of cancer is characterised by a minor change in a person's genetic material. A cell's DNA mutates in a particular area to the extent that the cell no longer divides in a controlled manner, but begins to grow uncontrollably. In many cases, this type of genetic ...


Page 1 From 63
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE